Visikol Revenue and Competitors

Hampton, NJ USA

Location

N/A

Total Funding

3D

Industry

Estimated Revenue & Valuation

  • Visikol's estimated annual revenue is currently $3.3M per year.(i)
  • Visikol's estimated revenue per employee is $119,000

Employee Data

  • Visikol has 28 Employees.(i)
  • Visikol grew their employee count by -7% last year.

Visikol's People

NameTitleEmail/Phone
1
Associate Director In Vitro and HistologyReveal Email/Phone
2
Study Director and Manager Histology and MicroscopyReveal Email/Phone
3
Chief Science OfficerReveal Email/Phone
4
Lab ManagerReveal Email/Phone
5
Office ManagerReveal Email/Phone
6
Human Resource ManagerReveal Email/Phone
7
Business Development LeadReveal Email/Phone
8
ScientistReveal Email/Phone
9
Senior ScientistReveal Email/Phone
10
Senior Image AnalystReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$3.3M28-7%N/AN/A
#2
$2.6M220%N/AN/A
Add Company

What Is Visikol?

Visikol is a contract research organization that is focused on transforming tissues into insights through the use of digital image analysis and advanced optical imaging. The company offers services to pharmaceutical companies in the areas of in vitro assays, digital pathology and whole mount tissue imaging. The team at Visikol are experts in advanced 3D cell culture models (e.g. organoids, spheroids, microtissues), developing customized image analysis solutions and high-throughput imaging (e.g. high content screening). Visikol also provides a suite of products and kits for use in advanced 3D tissue imaging.

keywords:N/A

N/A

Total Funding

28

Number of Employees

$3.3M

Revenue (est)

-7%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Visikol News

2022-04-17 - Organ-on-Chip Market to Reach $1.6 Bn, Globally, by 2030 at ...

BICO Group AB(Visikol); CN Bio Innovations Limited; Elveflow; Emulate, Inc. AxoSim Technologies LLC; Nortis Inc. Tara Biosystems...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.9M280%N/A
#2
$4.9M28-10%N/A
#3
$4.3M28-7%N/A
#4
$2.8M284%N/A
#5
$5.9M294%N/A